ISSN: 2329-9053

Журнал молекулярной фармацевтики и исследований органических процессов

Открытый доступ

Наша группа организует более 3000 глобальных конференций Ежегодные мероприятия в США, Европе и США. Азия при поддержке еще 1000 научных обществ и публикует более 700 Открытого доступа Журналы, в которых представлены более 50 000 выдающихся деятелей, авторитетных учёных, входящих в редколлегии.

 

Журналы открытого доступа набирают больше читателей и цитируемости
700 журналов и 15 000 000 читателей Каждый журнал получает более 25 000 читателей

Абстрактный

DRUG MANAGEMENT ANALYSIS IN THE DEPARTEMENT OF PHARMACY HOSPITAL NACIONAL GUIDO VALADARES DILI TIMOR LESTE 2017

Santana Martins

The Department of Pharmacy is a part of the hospital that is responsible for managing drugs which includes the selection, procurement, distribution and use of drugs. This study aims to analyse the level of efficiency of drug management in the Pharmacy Department of Hospital Nacional Guido Valadares Dili.

Research uses descriptive designs for retrospective and concurrent data. Retrospective observations include planning and drug use reports, financial reports, drug procurement reports, invoices, stock taking reports. Concurrent observation includes the average waiting time for patient prescription services. Data is collected quantitatively and qualitatively. Data obtained from all stages of drug management in the Pharmacy Department of the Hospital National Guido Valadares Dili were analysed by efficiency indicators using the Ministry of Health indicators (2008) and WHO (1993) then compared with other standards or research results.

The results of the study show that the management system that is not yet in accordance with the standards is: the selection stage, the suitability of the drug with DOEN TL (96.19%); stage of procurement, capital / funds available with all the funds needed (86.03%); allocation of funds for drug procurement (4.23%); suitability of planning with the actual use for each drug item (88.12%); procurement of each drug item per year (4.97 times); distribution stage, drug expiration and damage (20.76%).